175 related articles for article (PubMed ID: 31114720)
1. Induction of the Abscopal Effect with Immunotherapy and Palliative Radiation in Metastatic Head and Neck Squamous Cell Carcinoma: A Case Report and Review of the Literature.
Shinde A; Novak J; Freeman ML; Glaser S; Amini A
Cureus; 2019 Mar; 11(3):e4201. PubMed ID: 31114720
[TBL] [Abstract][Full Text] [Related]
2. The abscopal effect in head-and-neck squamous cell carcinoma treated with radiotherapy and nivolumab: a case report and literature review.
Forner D; Horwich P; Trites JR; Hollenhorst H; Bullock M; Lamond NWD
Curr Oncol; 2020 Dec; 27(6):330-335. PubMed ID: 33380865
[TBL] [Abstract][Full Text] [Related]
3. Abscopal Effect Following Immunotherapy and Combined Stereotactic Body Radiation Therapy in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma: A Report of Two Cases and Literature Review.
Choi JS; Sansoni ER; Lovin BD; Lindquist NR; Phan J; Mayo LL; Ferrarotto R; Su SY
Ann Otol Rhinol Laryngol; 2020 May; 129(5):517-522. PubMed ID: 31875405
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy orchestrates radiotherapy in composing abscopal effects: A strategic review in metastatic head and neck cancer.
Akbor M; Hung KF; Yang YP; Chou SJ; Tsai PH; Chien CS; Lin LT
J Chin Med Assoc; 2020 Feb; 83(2):113-116. PubMed ID: 31834023
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of head and neck squamous cell carcinoma (HNSCC). Immune checkpoint blockade.
Przybylski K; Majchrzak E; Weselik L; Golusiński W
Otolaryngol Pol; 2018 Sep; 72(6):10-16. PubMed ID: 30647199
[TBL] [Abstract][Full Text] [Related]
6. Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial.
Bozorgmehr F; Hommertgen A; Krisam J; Lasitschka F; Kuon J; Maenz M; Huber PE; König L; Kieser M; Debus J; Thomas M; Rieken S
BMC Cancer; 2019 Nov; 19(1):1074. PubMed ID: 31703637
[TBL] [Abstract][Full Text] [Related]
7. Successful Treatment of Refractory Squamous Cell Cancer of the Head and Neck with Nivolumab and Ipilimumab.
Schwab KS; Kristiansen G; Schild HH; Held SEA; Heine A; Brossart P
Case Rep Oncol; 2018; 11(1):17-20. PubMed ID: 29515404
[TBL] [Abstract][Full Text] [Related]
8. A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab.
Chandra RA; Wilhite TJ; Balboni TA; Alexander BM; Spektor A; Ott PA; Ng AK; Hodi FS; Schoenfeld JD
Oncoimmunology; 2015 Nov; 4(11):e1046028. PubMed ID: 26451318
[TBL] [Abstract][Full Text] [Related]
9. Overcoming immune-resistance in laryngeal cancer: a case report of the abscopal effect and nivolumab beyond progression.
Marco F; Gianluca A; Mariagrazia T; Luca EP
Immunotherapy; 2022 Oct; 14(14):1089-1095. PubMed ID: 36040238
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy Mythbusters in Head and Neck Cancer: The Abscopal Effect and Pseudoprogression.
Lauber K; Dunn L
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():352-363. PubMed ID: 31099687
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy in head and neck squamous cell carcinoma : Abscopal effects in combination with radiotherapy, extraordinary responses in combination with chemotherapy, and pseudoprogression].
Brix N; Dunn L; Seiwert T; Belka C; Lauber K
Internist (Berl); 2020 Jul; 61(7):682-689. PubMed ID: 32462252
[TBL] [Abstract][Full Text] [Related]
12. Abscopal effect in metastatic renal cell carcinoma.
Van de Walle M; Demol J; Staelens L; Rottey S
Acta Clin Belg; 2017 Aug; 72(4):245-249. PubMed ID: 27425038
[TBL] [Abstract][Full Text] [Related]
13. Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer—review of current data.
Swanson MS; Sinha UK
Oral Oncol; 2015 Jan; 51(1):12-5. PubMed ID: 25459157
[TBL] [Abstract][Full Text] [Related]
14. Time to Debunk an Urban Myth? The "Abscopal Effect" With Radiation and Anti-PD-1.
Seiwert TY; Kiess AP
J Clin Oncol; 2021 Jan; 39(1):1-3. PubMed ID: 32986527
[No Abstract] [Full Text] [Related]
15. Mucosal Melanoma: A Rare Entity and Review of the Literature.
Sohal RJ; Sohal S; Wazir A; Benjamin S
Cureus; 2020 Jul; 12(7):e9483. PubMed ID: 32766017
[TBL] [Abstract][Full Text] [Related]
16. Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report.
Endo M; Fukuda Y; Okada K; Ogawa K; Nakamura M; Takahashi S; Kawahara M; Akahane K; Nagai Y; Yamaguchi H; Nishino H; Mori H; Shirai K
Case Rep Oncol; 2023; 16(1):1345-1352. PubMed ID: 37946746
[TBL] [Abstract][Full Text] [Related]
17. Abscopal effect of high-dose-rate brachytherapy on pelvic bone metastases from renal cell carcinoma: a case report.
Suzuki G; Masui K; Yamazaki H; Takenaka T; Asai S; Taniguchi H; Nakamura T; Ukimura O; Yamada K
J Contemp Brachytherapy; 2019 Oct; 11(5):458-461. PubMed ID: 31749855
[TBL] [Abstract][Full Text] [Related]
18. Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases.
Houessinon A; Moreira A; Bettoni J; Schoonaker M; Sauzay C; Galmiche A; Coutte A; Biet A; Krzisch C; Chauffert B
Case Rep Oncol; 2020; 13(2):835-842. PubMed ID: 32884527
[TBL] [Abstract][Full Text] [Related]
19. Radiation generates an abscopal response and complete resolution of metastatic squamous cell carcinoma of the anal canal: a case report.
Joe MB; Lum JJ; Watson PH; Tonseth RP; McGhie JP; Truong PT
J Gastrointest Oncol; 2017 Dec; 8(6):E84-E89. PubMed ID: 29299375
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Łasińska I; Kolenda T; Teresiak A; Lamperska KM; Galus Ł; Mackiewicz J
Anticancer Agents Med Chem; 2019; 19(3):290-303. PubMed ID: 30198439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
